Please login to the form below

Not currently logged in
Email:
Password:

Chase adds former Allergan execs to leadership team

Scott Giacobello and Gary Charbonneau join

Chase Pharmaceuticals Scott GiacobelloCalifornian Chase Pharmaceuticals has made two appointments to its senior leadership team.

Scott Giacobello (pictured right) becomes chief financial officer at the clinical-stage biopharma company, bringing almost 25 years of experience in finance and accounting.

Most recently, Giacobello served as vice president of finance for global research and development at Allergan, and has held financial positions at Black & Decker and Ernst & Young.

Meanwhile, Gary Charbonneau (pictured below) has been appointed as senior vice president for regulatory affairs and operations.

Charbonneau joins Chase with over 25 years of experience in regulatory, quality and research and development operations.

He moves from Allergan, where he spent 14 years in a number of senior regulatory positions, including his most recent role as vice president of international regulatory affairs.

Chase Pharmaceuticals Gary CharbonneauCharbonneau also brings experience from Amgen, Baxter, Novo Nordisk and Roche

Douglas Ingram, chief executive officer at Chase, said: “I could not be more delighted to welcome Scott and Gary to Chase.

“With its robust intellectual property, pharmaceutical assets and elegant development strategy, Chase has the opportunity to profoundly reshape the approach to the symptomatic treatment of Alzheimer's disease.

“Scott and Gary have the proven track records, enthusiasm and commitment to operational excellence that will help Chase succeed in improving the lives of millions of patients suffering from this devastating disease.”

20th June 2016

From: Sales, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics